Barclays
XTNT icon

Barclays’s Xtant Medical Holdings XTNT Stock Holding History

Barclays’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-187
Closed -$79 – 5769
2026
Q2 		$79 Buy
+187
New +$90 ﹤0.01% 5212
2025
Q4 		– Sell
-8
Closed -$5 – 5767
2025
Q3 		$5 Buy
+8
New +$5 ﹤0.01% 5416
2021
Q2 		– Sell
-2,951
Closed -$7K – 5108
2021
Q1 		$7K Buy
+2,951
New +$6.3K ﹤0.01% 4473
2020
Q3 		– Sell
-20
Closed – – 5635
2020
Q2 		$0 Buy
+20
New +$18 ﹤0.01% 6339
2018
Q4 		– Sell
-2
Closed – – 7394
2018
Q3 		$0 Sell
2
-388
-99% -$2.05K ﹤0.01% 7438
2018
Q2 		$2K Buy
+390
New +$2.61K ﹤0.01% 6854

Other funds holding XTNT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Crescent Grove Advisors
Crescent Grove Advisors Lake Forest, Illinois $1.18B AUM 13.12% 1-Year Est. Return
Wiregrass Investment Management
Wiregrass Investment Management Thomasville, Georgia $144M AUM 19.4% 1-Year Est. Return
Wedbush Securities
Wedbush Securities Los Angeles, California $3.95B AUM 25.45% 1-Year Est. Return
Kestra Advisory Services
Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
Valley Wealth Managers
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Barclays's XTNT Position: Q3 2026 in Review

Barclays sold out of Xtant Medical Holdings (XTNT) in Q3 2026, closing a stake of 187 shares — an estimated $79 sold.

Barclays first reported a position in XTNT in Q2 2018 and held it in 6 quarters. The position peaked at $7K in Q1 2021. 9 funds tracked by Wall St. Rank hold XTNT as of Q3 2026.

  • Barclays reported no remaining Xtant Medical Holdings position as of Q3 2026 after selling out during the quarter.
  • Barclays sold 187 Xtant Medical Holdings shares in Q3 2026, an estimated $79.
  • Barclays first reported a position in Xtant Medical Holdings in Q2 2018 and held it in 6 quarters.
  • Barclays's Xtant Medical Holdings position peaked at $7K in Q1 2021.
  • 9 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.